Prosecution Insights
Last updated: July 17, 2026
Application No. 18/553,153

NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE SOLUTION BATTERY, AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION BATTERY

Non-Final OA §103
Filed
Sep 28, 2023
Priority
Mar 30, 2021 — JP 2021-058532 +1 more
Examiner
MENDOZA, KENT GREGORY
Art Unit
1754
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Central Glass Co. Ltd.
OA Round
1 (Non-Final)
Grant Probability
Favorable
1-2
OA Rounds

Examiner Intelligence

Grants only 0% of cases
0%
Career Allowance Rate
0 granted / 0 resolved
-65.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
9 currently pending
Career history
6
Total Applications
across all art units

Statute-Specific Performance

§103
47.4%
+7.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status Claims 1-11 are pending. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-11 are rejected under 35 U.S.C. 103 as being unpatentable over Koyama et al. (US20200274200A1). Regarding Claim 1, Koyama discloses a nonaqueous electrolyte solution ([0059-0060]), comprising a solute ([0058]) and a nonaqueous organic solvent ([0059-0060]). Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones, tetramethylene disulfones, and hexaethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of the sulfonyl group members on the respective rings. Positional isomers of the C3-C6 cyclic sulfones taught generically by Koyama are analogous to the current invention by virtue of being in the same field of endeavor, namely additives of nonaqueous electrolyte solutions. Before the effective filing date of the claimed invention, it would have been obvious to a person having ordinary skill in the art that the sunfonyl groups must be in some certain positions in order to include those two sunfonyl groups in the ring, and therefore find it obvious to routinely design the sulfonyl groups to be separated by at least one ring member carbon in either direction, thus reading on the recited Formula (1). Exemplary cyclic disulfones satisfying the constraints of the instant Formula (1) are depicted in Figure A. PNG media_image1.png 1199 1429 media_image1.png Greyscale Figure A: Comparison of (I) the instant Formula (1) to (II-IV) exemplary cyclic disulfones outlined in the disclosure of Koyama et al. (US20200274200A1). Regarding Claim 2, Koyama discloses the electrolyte solution according to Claim 1. Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones, tetramethylene disulfones, and hexaethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of Claim 2, wherein the A is a -CH2 group, the D is a -C2-H4 or C3H6- group, and m and n both represent 2. However, it would have been obvious to a person having ordinary skill in the art before the effective filing date of the current invention to have selected a positional isomer satisfying the constraints of Claim 2 wherein the sulfonyl group members are separated by at least one ring-member carbon in either direction, because doing so would amount to no more than choosing among the finite options defined by Koyama’s disclosure of a trimethylene disulfone or a tetramethylene disulfone. Exemplary cyclic disulfones satisfying the constraints of the instant Claim 2 are depicted in Figure AII-III. Regarding Claim 3, Koyama discloses the electrolyte solution according to Claim 1. Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones, tetramethylene disulfones, and hexaethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of compounds described by the instant Claim 3. However, it would have been obvious to a person having ordinary skill in the art before the effective filing date of the current invention to have selected a positional isomer of the trimethylene disulfone or tetratmethylene disulfone disclosed by Koyama that satisfies the constraints of Claim 3 because doing so would amount to no more than choosing among the finite options defined by Koyama’s disclosure. Exemplary cyclic disulfones satisfying the constraints of the instant Claim 3 are depicted in Figure AII-III, corresponding respectively to the compounds (1e) and (1n) of Claim 3. Regarding Claim 4, Koyama discloses the electrolyte solution according to Claim 3. Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones, tetramethylene disulfones, and hexaethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of compounds described by the instant Claim 4. However, it would have been obvious to a person having ordinary skill in the art before the effective filing date of the current invention to have selected a positional isomer of the trimethylene disulfone or tetratmethylene disulfone disclosed by Koyama that satisfies the constraints of Claim 4 because doing so would amount to no more than choosing among the finite options defined by Koyama’s disclosure. Exemplary cyclic disulfones satisfying the constraints of the instant Claim 4 are depicted in Figure AII-III, corresponding respectively to the compounds (1e) and (1n) of Claim 3. Regarding Claim 5, Koyama discloses the electrolyte solution according to Claim 3. Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones, tetramethylene disulfones, and hexaethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of compounds described by the instant Claim 5. However, it would have been obvious to a person having ordinary skill in the art before the effective filing date of the current invention to have selected a positional isomer of the trimethylene disulfone or tetratmethylene disulfone disclosed by Koyama that satisfies the constraints of Claim 5 because doing so would amount to no more than choosing among the finite options defined by Koyama’s disclosure. Exemplary cyclic disulfones satisfying the constraints of the instant Claim 5 are depicted in Figure AII-III, corresponding respectively to the compounds (1e) and (1n) of Claim 3. Regarding Claim 6, Koyama discloses the nonaqueous electrolyte solution according to Claim 1. Koyama further discloses wherein the nonaqueous organic solvent contains at least one selected from the group consisting of cyclic carbonate and chain carbonate ([0061],[0181]). Regarding Claim 7, Koyama discloses the nonaqueous electrolyte solution of Claim 6. Koyama further discloses wherein ethylene carbonate, ethyl methyl carbonate, and dimethyl carbonate are mixed as a nonaqueous organic solvent ([0607]). Regarding Claim 8, Koyama discloses the nonaqueous electrolyte solution according to Claim 1, wherein the content of a sulfone-based compound is between 0.3% and 30% by volume in 100% by volume of the solvent ([0477]). Koyama further discloses use of C3-C6 cyclic sulfones that can feature 2 sulfonyl groups, including trimethylene disulfones and tetramethylene disulfones ([0471-0472]); but does not explicitly disclose the positional relationships of the sulfonyl group members on the respective rings. However, it would have been obvious to a person having ordinary skill in the art before the effective filing date of the current invention to have selected a positional isomer satisfying the constraints of the instant Formula (1), wherein the sulfonyl group members are separated by at least one ring-member carbon in either direction, because doing so would amount to no more than choosing among the finite options defined by Koyama’s disclosure. Exemplary cyclic disulfones satisfying the constraints of the instant Formula (1) are depicted in Figure A. Using the exemplary compounds 1,3-dithiolane-1,1,3,3-tetraoxide or 1,3-dithiane-1,1,3,3-tetraoxide in Koyama’s disclosed embodiment of 1.2 molar LiPF6 solution in ethylene carbonate:ethyl methyl carbonate:dimethyl carbonate in a volumetric ratio of 30:30:40 ([0607]) and the conversions calculated from the values described in Table 1, Koyama’s disclosed range of 0.3%-30% of sulfone-based compound by volume in 100% by volume of the solvent ([0477]) substantially overlaps and consequently anticipates the instant application’s claimed range of 0.01% by mass to 10.0% by mass of the compound of Formula (1) with respect to a total amount of the compound represented by Formula (1), the solute, and the nonaqueous organic solvent, as shown in Table 2. Table 1: Values of physical characteristics for compounds in a nonaqueous electrolyte solution, as disclosed by Koyama et al. (US20200274200A1) Compound Physical characteristic Value of physical characteristic Evidentiary reference 1,3-dithiolane-1,1,3,3-tetraoxide Density (grams per cubic centimeter) 1.67 ChemicalBook 1,3-dithiane-1,1,3,3-tetraoxide Density (grams per cubic centimeter) 1.54 GuideChem LiPF6 Molecular weight (grams/mole) 151.91 Sigma Aldrich Ethylene carbonate Density (grams per cubic centimeter) 1.321 Sigma Aldrich Ethyl methyl carbonate Density (grams per cubic centimeter) 1.006 Sigma Aldrich Dimethyl carbonate Density (grams per cubic centimeter) 1.069 Sigma Aldrich Table 2: Comparison of the compositional ranges of a given compound as taught by Koyama et al. (US20200274200A1) ([0477],[0607]) to the claimed range of the instant Claim 8 Compound Disclosed range as a volumetric percentage of the nonaqueous organic solvent Disclosed range equivalent as a mass percentage of the total electrolyte solution Instant application claimed range as a mass percentage of the total electrolyte solution 1,3-dithiolane-1,1,3,3-tetraoxide [0.3%,30%] [0.34%, 33.57%] [0.01%, 10%] 1,3-dithiane-1,1,3,3-tetraoxide [0.3%,30%] [0.31%, 31.79%] [0.01%, 10%] Regarding Claim 9, Koyama discloses the nonaqueous electrolyte solution according to Claim 1. Koyama further discloses the nonaqueous electrolyte solution further comprising lithium difluorophosphate (abstract). Regarding Claim 10, Koyama discloses a nonaqueous electrolyte solution battery ([0494]), comprising: a positive electrode ([0494]), a negative electrode ([0494]); and the nonaqueous electrolyte solution according to Claim 1 ([0494]). Regarding Claim 11, Koyama discloses a method for producing a nonaqueous electrolyte solution battery ([0611]), comprising: preparing the nonaqueous electrolyte solution according to Claim 1 ([0611]); and filling an empty cell including at least a positive electrode and negative electrode with the nonaqueous electrolyte solution ([0611]). References Cited But Not Relied Upon The following prior art made of record and not relied upon at this time is considered pertinent to the applicant’s disclosure: Mio et al. (US20130040209A1) discloses a cyclic sultone compound for use in nonaqueous electrolyte solution. Nakazawa et al. (JP2016181508A – Global Dossier machine translation furnished with the Office Action) teaches use of trimethylene disulfones, tetramethylene disulfones, and hexamethylene disulfones in a nonaqueous electrolyte solution to improve cycle and storage characteristic in a secondary battery. Liu et al. (CN111205267A – Espacenet machine translation furnished with the Office Action) discloses use of cyclic disulfones as additives in a nonaqueous electrolyte solution. Fujimoto et al. (JP2014105156A – Global Dossier machine translation furnished with the Office Action) discloses cyclic disulfone compounds that can be used in nonaqueous secondary battery electrolytes. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Kent G. Mendoza whose telephone number is (571)482-9953. The examiner can normally be reached Monday-Thursday 8:30-5:00 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Susan Leong can be reached at (571)270-1487. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /K.G.M./Examiner, Art Unit 1754 /JAMES M ERWIN/Primary Examiner, Art Unit 1725 06/08/2026
Read full office action

Prosecution Timeline

Sep 28, 2023
Application Filed
Jun 11, 2026
Non-Final Rejection mailed — §103 (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
Grant Probability
Low
PTA Risk
Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month